top-banner

METHODS AND TECHNOLOGIES

Copy number variation analysis

CNV ANALYSIS

The reliable identification of single nucleotide variants (SNVs) and small insertions and deletions (InDels) with next-generation sequencing (NGS) technologies has been a cornerstone of routine diagnostics. However, conventional short-read sequencing methods face technical limitations when detecting larger genomic regions (>150bp) with gene dosage variations. To address this, molecular genetic diagnostics have traditionally relied on multiplex PCR combined with fragment length analysis (MLPA) for identifying copy number differences in specific target regions. Despite its high sensitivity, MLPA is constrained by its limited availability, with commercial kits covering only a small fraction of the genomic regions that can be analyzed via NGS.

An alternative solution lies in indirectly identifying copy number variations (CNVs) from existing NGS data. Various algorithms, both commercial and open-source, have been developed to detect CNVs and structural variants (SVs) using diverse methodologies (Pirooznia, Goes et al., 2015). The choice of detection method depends on the sequencing approach. Structural changes such as deletions, duplications, and complex rearrangements (e.g., translocations, inversions) create breakpoints in the DNA. To detect these structural changes, it is necessary to detect the breakpoints using whole genome sequencing (WGS) without PCR amplification. However, due to its extensive scope and high costs, WGS remains impractical for many molecular genetic diagnostic applications. Instead, targeted regions of interest (ROIs) are enriched and sequenced using panel sequencing. Read-depth algorithms are particularly effective for such applications. These algorithms normalize enrichment data across a patient cohort by determining the depth of coverage (number of sequenced DNA fragments) at each genomic position and comparing it to a reference dataset.

Leveraging this approach, a CNV analysis pipeline was developed in Martinsried, Germany, enabling the detection of gene dosage differences at the level of individual targets or exons (Becker, Ziegler et al., 2018). To enhance the pipeline’s specificity, it integrates three independent algorithms for CNV detection. This multi-algorithm approach ensures highly accurate identification of heterozygous, hemizygous, and homozygous CNVs within the analysis region (Ziegler, Becker et al., 2018). This methodology provides significant diagnostic advantages, particularly in scenarios where CNV analysis was previously unfeasible or restricted to a limited number of genes (Busse, Ibisler et al., 2018).

WAYS TO PARTNER WITH US

TarCET IVD Kits

CE-IVD kits containing reagents
for hereditary indications in
an easy-to-use kit form

Learn more

Technology Transfer

Out-of-the-box genetics workflow
from sequencing to reporting
for non-invasive prenatal testing

Learn more

Genetic Testing Laboratory

Your partner for
all genetic tests

Learn more

Contact Us

Please get in touch with us
for any questions, inquiries,
feedback, or with any
comments you might have.

Learn more

BLOG ARTICLES

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f…

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced …

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso…

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co…

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study…

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a…

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area…

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th…

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor…

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant…

Read more

OUR NETWORK